[News Brief] CeleCor Completes FDA Application for Heart Attack Drug
CeleCor Therapeutics has completed its New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for investigational…
CeleCor Therapeutics has completed its New Drug Application (NDA) submission to the US Food and Drug Administration (FDA) for investigational…
Chime Biologics has inaugurated its GMP-2 manufacturing facility in Wuhan, China, as part of its ongoing collaboration with life sciences…
SK Biopharmaceuticals and Insilico Medicine have entered a research and development collaboration to discover drug candidates for neuroimmune disorders of…
IHLD MedTech has secured an initial investment commitment from Singapore-listed healthcare technology firm UltraGreen.ai to support the growth of its…
AnHorn Medicines has received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration and Index Case designation…
SystImmune and Sichuan Biokin Pharmaceutical have received regulatory approval in China for iza-bren (BL-B01D1) to treat recurrent or metastatic nasopharyngeal…
Sonire Therapeutics KK has received funding through Japan’s New Energy and Industrial Technology Development Organization (NEDO) Deep-Tech Startups Support Program…
Axcelead Drug Discovery Partners (DDP), Inc. has entered a collaboration with Lilly TuneLab, an artificial intelligence and machine learning drug…
China-based Innovent Biologics and Pfizer have entered a global licensing and collaboration agreement to research and develop twelve early-stage cancer…
China-based Haisco Pharmaceutical Group has entered a licensing and research collaboration with Eli Lilly and Company to discover and develop…